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PRETREATMENT IN A RAT MODEL OF INTESTINAL
ISCHEMIA-REPERFUSION INJURY: A
HISTOMORPHOMETRIC STUDY
Oscar Haruo Higa, Edwin Roger Parra, Alexandre Muxfeldt Ab’Saber, Cecilia
Farhat, Rita Higa, and Vera Luiza Capelozzi
Higa OH, Parra ER, Ab’Saber AM, Farhat C, Higa R, Capelozzi VL. Protective effects of ascorbic acid pretreatment in a
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BACKGROUND:. Ascorbic acid has shown promise in attenuation of intestinal ischemia-reperfusion (I/R) injury. The aim of
this study was to determine the protective effects of ascorbic acid on intestinal morphology during IR injury in rats.
MATERIALS AND METHODS:. We examined morphological changes in the small intestine of Wistar rats after (i) 40 minutes
of ischemia (I), (ii) ischemia followed by 30 min of reperfusion (IR), (iii) ischemia with ascorbic acid (IA), (iv) ischemia followed
by reperfusion and ascorbic acid (IRA) and (v) in a sham group (S). We used morphometry to evaluate the amount of villous
architecture, crypts, necrosis, hemorrhagic infarcts and inflammatory cells at the mesenteric and antimesenteric borders of the
small intestine.
RESULTS: Ascorbic acid caused a significant reduction of antimesenteric villous hemorrhagic infarction (p<0.05) of the small
intestine after ischemia followed by reperfusion as well as villous necrosis reduction at both borders after ischemia (p<0.05). The
lesions found in the small intestine were more prominent along the antimesenteric margin.
CONCLUSIONS: Ascorbic acid pretreatment has a protective effect against the intestinal morphological lesions induced by
ischemia-reperfusion injury in rats.
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INTRODUCTION
Intestinal ischemia and subsequent reperfusion (IR) injury
is encountered in a variety of clinical conditions, including
acute mesenteric ischemia, intestinal obstruction, incarcerated
hernia, small intestine volvulus, and necrotizing enterocoli-
tis. The consequences of mesenteric ischemia are devastating
to the patient and usually result in diarrhoea, malabsorption,
short bowel syndrome and even death1. In addition, IR inju-
ries have been a key problem with respect to successful or-
gan preservation in small intestine transplantation2.
The gastrointestinal tract is one of the most sensi-
tive tissues to ischemia and reperfusion 3. Thus, there is
great interest concerning methods to verify protective
mechanisms in extensive small intestine lesions that can
shorten the patient’s life. For the transplantation treat-
ment to be effective, we must identify and protect small
intestine morphological changes after IR injuries. In this
regard, many authors have studied small intestine mor-
phological aspects to determine what might correlate to
the pathogenesis of the resulting injury and protective
mechanisms4. Because free oxygen radicals are involved
in ischemia/reperfusion injuries 5, 6, 7 a group of anti-oxi-
dants has been targeted as potential useful protective
agents against morphological changes identified after
small intestine injuries 8. Among these, ascorbic acid has
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shown promise. Ascorbic acid is water-soluble with re-
ducing and chelating properties; it thus washes out free
radicals produced during ischemia, and scavenges reac-
tive oxidants produced immediately after reperfusion 9.
Nakamura’s study demonstrated that ascorbic acid pre-
vents IR injuries 10, but the quantitation of morphologi-
cal changes reported is uncertain. In fact, many meth-
ods have been proposed to quantify morphological
changes induced by IR in organs. Some have used bi-
nary cut-points to define the presence of morphological
changes. Others have expressed the morphological
changes in crosses, and yet, others have expressed them
semi-quantitatively 11. In this study, we assume that
ascorbic acid pretreatment has a protective effect against
the intestinal morphological lesions induced by
ischemia-reperfusion injury in rats. To test the hypoth-
esis, we quantified the intestinal morphological lesions
by histomorphometry and herein report our results.
MATERIALS AND METHODS
Intestinal I/R Injury Model
This study was approved by the Ethics Committee of
the University São Paulo Medical School. The experimen-
tal design was as follows: 50 male Wistar rats
weighing between 250 and 300g were divided in 5 groups
(n = 10 in each group): sham (S), ischemia (I); ischemia/
reperfusion (IR), ischemia/ascorbic acid (IA) and
ischemia/reperfusion/ascorbic acid (IRA). Animals in the
ischemia and ischemia/reperfusion groups received 2 ml
of sterile saline solution (0.9% NaCl) into the peritoneal
cavity one hour before the surgical procedure. The
ischemia/ascorbic acid and ischemia/reperfusion/ascorbic
acid groups underwent the same experimental procedure
but with an intraperitoneal injection of 2 mmol/kg of
ascorbic acid (Sigma Chemical Co St. Louis. Mo. USA)
suspended in saline solution (total volume=2 ml). The rats
were anesthetized with an 80mg/kg ketamine intramus-
cular injection (Dopalen, Agribands of Brazil, Paulínea,
SP) and 10 mg/kg of xylazine (Dopaser, Calier Labora-
tory of Brazil). An abdominal incision was performed to
expose the superior mesenteric artery in the ischemia
group and occluded for 40 minutes using a micro vascu-
lar clamp. The occluding clamp was removed after 40
minutes for a reperfusion period for 30 additional min-
utes in the ischemia/reperfusion group. Rats in the sham
group were submitted to the abdminal incision but not to
the occlusion/reperfusion. At the end of each procedure rats
were sacrificed and the proximal jejunum was processed
using standard histological techniques including forma-
lin fixation, dehydration and paraffin embedding, and
were subsequently cut in 4 µm sections and stained with
Haematoxylin and Eosin. The normal intestine sample of
the sham group did not undergo artery manipulation.
Morphometric Study
We performed a morphometric analysis of the mesenteric
and antimesenteric small intestine borders. Selection of in-
testinal compartments to be analyzed as well as cell counts
were performed by an investigator blinded to group alloca-
tion. An integrating eyepiece with a coherent system made
of a 100-point grid consisting of 50 lines of known length
coupled to a light microscope was used. At X100 and X400
fractional areas of villous, crypts, necrosis, hemorrhagic
infarctions and inflammatory cells were determined by the
point-counting technique 12. We counted all points falling on
these components and divided them by the total number of
points. We averaged this over 10 non-overlapping micro-
scopic fields in each case to obtain a result as a percentage
of measured structures as shown below.
Fractional Area (A/A) = Zp(struct.)/Zp(sect)
where the Fractional Area (A/A) is equal to the number of
points overlying villous, crypts, necrosis and inflammatory
cells [Zp(struct)] divided by the total number overlying
small intestine tissue [Zp(sect)]. The intra and interobserver
variability were less than 10%.
Statistical Analysis
The normality of the data (Kolmogorov-Smirnov test
with Lilliefor´s correction) and the homogeneity of variances
were tested. One-way analysis of variance (ANOVA) was
used to compare the groups.  When variances were differ-
ent, a Dunnet test was applied (global a=5%), whereas a
Tukey test was used for equal variances. Control (ischemia
and ischemia/reperfusion) and ascorbic groups (ischemia/
ascorbic acid and ischemia/reperfusion/ascorbic acid) were
compared by Student’s T test for independent samples. In
all instances, the significance level was set at 5%.
RESULTS
Morphological Changes after Ischemia, Ischemia
Reperfusion and Ascorbic Acid Treatment. Figure 1 illus-
trates the intestinal architecture of the sham, ischemia, IR,
and IR/ascorbic acid groups. The intestinal wall of the sham
group shows the maintenance of its architecture (Figure 1A
and 1E). In contrast, intestinal specimens of animals who
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underwent ischemia or ischemia reperfusion show a distor-
tion of the architecture through the presence of necrosis of
the villi (Figure 1B and 1F) and a decrease of villi length
(Figure 1C and 1G). This contrasts with a degree of protec-
tion regarding necrosis and length of the villi, seen in the I/
ascorbic acid and IR/ascorbic acid groups (Figure 1D and
1H). Equally important morphological changes, such as
hemorrhagic infarctions, are present at the mesenteric bor-
der in ischemia group and at the antimesenteric border in
the IR groups (Figure 1I and 1J).
Morphometric Changes after Ischemia, Reperfusion
and Ascorbic Acid Treatment. Graphic illustrations of his-
tological quantitation in the five groups of rats are show
in Figures 2A-C. Antimesenteric villi were significantly
shorter in the ischemia-reperfusion group when compared
to the ischemia group (0.34 vs. 0.45; p=0.04). The degree
of antimesenteric haemorrhagic infarction in the IR group
was greater than that observed in the ischemia group (0.63
vs. 0.42; p=0.01). IR rats presented a greater degree of
antimesenteric haemorrhagic infarction when compared to
corresponding IR/ascorbic acid rats (0.63 vs. 0.36;
p=0.009). The small intestine exposed to ischemia pre-
sented significantly more mesenteric and antimesenteric
villous necrosis, respectively, when compared to I/ascor-
bic acid (0.15 vs. 0.04, p=0.004; 0.32 vs. 0.19; p=0.01).
Crypt and inflammatory cells did not show statistical dif-
ferences among the groups. The main point of these results
was the significant difference concerning villi, necrosis and
hemorrhagic infarction at the mesenteric and antimesenteric
borders (Figure 2A-2B) and the protective effect of ascor-
bic acid on the morphological changes found in the IR
group.
DISCUSSION
The most likely reason why abdominal surgical proce-
dures and trauma are associated with high morbidity and
mortality is the fact that ischemia can easily injure the in-
testine, and subsequent reperfusion can increase the dam-
age to the mucosa. Park et al 13 demonstrated that most of
the tissue damage produced by the widely employed re-
gional hypotension model occurs at the time of the
reperfusion13, 14. Other organs may also be affected15 The
question of interest is whether pretreatment has a protec-
tive effect and whether additional information gathered
from small intestine tissue analysis can help us identify the
extension and severity of the morphological changes due
to ischemia.  In this context, experimental therapeutic
measures have been successfully tested to attenuate intes-
tinal ischemia-reperfusion injury in animal models includ-
ing ischemic preconditioning 16,17; anti complement 18; anti
leukocyte 19; anti-inflammatory therapies 20, 21 with
fluorocarbons, glutamine and glycine supplementation 22;
enteral feeding 23 and antioxidants 24. Among the antioxi-
dants, ascorbic acid 10 has been specially noted. In these
situations, a decreased expression of IR injury detected by
histopathological analysis has been associated with
favorable outcome of the IR injury.  Thus, for all reasons,
it should not be surprising that ascorbic acid pretreatment
has a protective effect on intestinal ischemia-reperfusion
injury in rats; our results confirm this point and stress the
Figure 1. Intestinal architecture of the sham (A), ischemic (B), ischemic/
reperfusion (C) and ischemic/reperfusion/ascorbic acid groups (D), stained
with Hematoxilyn and Eosin. Note the maintenance of the architecture of
intestine wall in sham group (E). Distortion of the architecture by villous
necrosis (F) and decrease of villous (G) are visualized in intestine specimens
of animals with ischemia and ischemia reperfusion. In contrast, ischemia/
reperfusion/ascorbic acid treated animals (H) show decrease of villous
necrosis and increase in villous cell. Different histoanatomical localization
of hemorrhagic infarct was observed for ischemia and ischemia-reperfusion
groups. In ischemia groups hemorrhagic infarct was present at the mesenteric
border (I) whereas in ischemia-reperfusion groups the antimesenteric border
was affected (J).
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importance of a quantitative assessment of injury after
small intestine ischemia.
We have recently shown the objective importance of
quantification of histopathological parameters25  Is this
study, we have confirmed and quantified the protective ef-
fects of ascorbic acid pretreatment in a rat model of intes-
tinal ischemia-reperfusion injury using an objective
histomorphometric method. Subjectivity is minimized and,
equally important, inter and intra-observer variability de-
creased. The method also facilitates the comparison of the
obtained results and allows evaluation of different interven-
tion mechanisms with precision.
We found that necrotizing changes after small intes-
tine ischemia and reperfusion, without ascorbic acid pro-
tection, was associated with increased villous necrosis
and hemorrhagic infarct. Thus, for instance, villous
necrosis extension was significantly related to small in-
testine ischemia and reperfusion, and ascorbic acid treat-
ment reduced the extension of necrosis, and this was also
significantly related to most of the contramesenteric in-
testinal border. Most interesting was the quantitative re-
lationship we found between ascorbic acid treatment and
mucosal hemorrhagic infarct. Similar findings were re-
ported by Nakamura and colleagues10. Nilsson et al17
have proposed the countercurrent O2 exchange hypoth-
esis to explain the marked susceptibility of intestinal villi
to ischemia. According to this hypothesis, the villus tips
become virtually anoxic in spite of an unaltered mucosal
blood flow due to shunting of oxygen between the
arterioles and venules at the base of the villus. Support
for this theory is provided by the observation that
ischemic injury to the small bowel is most severe at the
tip and is attenuated by intraluminal perfusion with oxy-
genated saline26. A variety of associations between ascor-
bic acid and IR injury has been described recently27-31.
Cizova et al27 demonstrated that the ascorbic and uric
acid concentrations increased generally after IR in com-
parison to intact controls, but this increase was not suf-
ficient to prevent lipid peroxidation in serum and intes-
tinal mucosa. In short, the small molecular antioxidants
measured did not contribute to the phenomenon of
ischemic preconditioning. In this context the increased
ascorbic acid may contribute to the improvement of the
IR injury. Now, we have quantitatively demonstrated that
in small intestine injury there is an association between
villous necrosis and hemorrhagic infarct, and that ascor-
bic acid pretreatment attenuates these alterations; to the
best of our knowledge, this is the first report of this as-
sociation by quantitative assessment. The association
between villous necrosis and hemorrhagic infarct to
ascorbic acid treatment suggest that small intestine
ischemia manufactures and secretes higher levels of free
radicals, all of which facilitates cellular injury and tis-
sue destruction 5, 16,17. Thus, increased amount of villous
Figure 2. Fractional area of anti mesenteric and mesenteric villous (A),
hemorrhagic infarct (B), villous necrosis (C) according to the sham, ischemia,
ischemia/reperfusion, ischemia/ascorbic acid and ischemia/reperfusion/
ascorbic acid.
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necrosis may be more of a primary event, and increased
hemorrhagic infarct more of a secondary event. Regard-
less of the mechanism, quantitative assessment of IR in-
jury provides important information in small intestine
ischemia
We have also showed that in ischemia-reperfusion in-
juries there is an improvement of hemorrhagic infarction
at the antimesenteric border after ascorbic acid treatment
and to the best of our knowledge this is the first report of
this association using a quantitative approach. Whereas only
three prior studies with ascorbic acid were able to show
any significant relationship between morphological changes
and small intestine ischemia-reperfusion 10, 23, 24 our results
show that the quantitative assessment of histopathological
parameters provides more information than the qualitative
pathological assessment. Furthermore, we describe im-
provement of hemorrhagic infarction at the antimesenteric
border after ascorbic acid treatment and again, to the best
of our knowledge this is the first report of this association
using a quantitative approach. Thus, a quantitative assess-
ment of intestinal ischemia offers the potential to guide the
control of risk in patients after surgical resection of small
intestine.
In summary, this study demonstrated the consequences
of small bowel ischemia in a rat model, with and without
pre-treatment with ascorbic acid, by a quantitative
pathologic/histomorphometric study. Ischemia-reperfusion
resulted in more injury than ischemia alone and that pre-
treatment with ascorbic acid resulted in protection, espe-
cially in the endpoints of hemorrhagic infarction and necro-
sis. This finding raises the possibility of using ascorbic acid
before surgical procedures that involve IR periods. Some
limitations of this study should be highlighted: experimen-
tal studies other than histological will be required to verify
if pre-treatment leads to better outcome in terms of ani-
mal survival. Enzyme function must be measured, and a
dose-response injury methodology will have to be em-
ployed. Long term follow-up, using this model with exami-
nation of the bowel one or two days later will probably be
more convincing of its protective effects.
RESUMO
Higa OH, Parra ER, Ab’Saber AM, Farhat C, Higa R,
Capelozzi VL.  Efeito protetor do pré-tratamento com ácido
ascóbico em modelo experimental de isquemia-reperfusão
intestinal: um estudo histomorfométrico. Clinics.
2007;62(3):315-20.
INTRODUÇÃO: O ácido ascórbico tem se mostrado
como um agente promissor na atenuação da lesão causada
pela isquemia/reperfusão (IR). O objetivo deste estudo foi
determinar os efeitos protetores do ácido ascórbico na
morfologia intestinal durante a IR em ratos.
MATERIAL E MÉTODOS: Examinamos alterações
morfológicas no intestino delgado de ratos do tipo Wistar.
Após 40 minutos de isquemia (I), isquemia seguida de
reperfusão (IR), isquemia com tratamento com ácido
ascórbico (IA), isquemia seguida por 30 minutos de
reperfusão e tratamento com ácido ascórbico (IRA) e do
grupo sham (S). Utilizamos a morfometria para avaliar
quantitativamente a arquitetura dos vilos da mucosa in-
testinal, criptas intestinais, necrose, hemorragia, células
inflamatórias nas bordas mesentéricas e antimesentéricas
do intestino delgado.
RESULTADOS: O ácido ascórbico causou uma redução
significativa (p<0,05) no infarto hemorrágico dos vilos
intestinais da borda antimesentérica do intestino delgado
após isquemia seguida por reperfusão, bem como redução
da necrose dos vilos em ambas as bordas após a isquemia
(p<0.05). As lesões presentes no intestino delgado foram
mais proeminentes na borda antimesentérica.
CONCLUSÕES: O pré-tratamento com ácido ascórbico
atenuou ou reduziu significativamente as alterações
morfológicas no intestino delgado induzidas pela
isquemia-reperfusão.
UNITERMOS: Intestino delgado, Isquemia reperfusão,
Análise morfométrica, Acido ascórbico, Isquemia.
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